CERGENTIS B V has a total of 18 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in EPO (European Patent Office), United Kingdom and Australia. Its main competitors in its focus markets biotechnology are GENPOINT AS, BEIJING VICA BIOTECH CO LTD and SINO GENO MAX CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | United Kingdom | 3 | |
#3 | Australia | 2 | |
#4 | Israel | 2 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | Hungary | 1 | |
#8 | New Zealand | 1 | |
#9 | Serbia | 1 | |
#10 | United States | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | De Laat Wouter Leonard | 7 |
#2 | Van Min Max Jan | 7 |
#3 | De Wit Elzo | 3 |
#4 | Splinter Erik Cornelis | 3 |
#5 | Jan Max Van Min | 2 |
#6 | Leonard Wouter De Laat | 2 |
#7 | De Laat Wouter | 1 |
#8 | Wouter Leonard De Laat | 1 |
#9 | Van Min Max | 1 |
#10 | Knoch Tobias | 1 |
Publication | Filing date | Title |
---|---|---|
GB202101819D0 | Method | |
GB202006550D0 | Method | |
GB202006546D0 | Method | |
AU2014349817A1 | Method for analysing the interaction of nucleotide sequences in a three-dimensional DNA structure | |
WO2014129894A1 | Sequencing strategies for genomic regions of interest |